Exact Mass: 619.2294698
Exact Mass Matches: 619.2294698
Found 114 metabolites which its exact mass value is equals to given mass value 619.2294698
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-[(2S)-3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(Z)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide
(1R,5S)-N-Cyclopropyl-7-(4-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)phenyl)-N-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide
N-formylasimilobine 2-O-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside|tinoscorside A
C30H37NO13 (619.2264792000001)
Asp His Trp Tyr
C30H33N7O8 (619.2390498000001)
Asp His Tyr Trp
C30H33N7O8 (619.2390498000001)
Asp Asn Trp Trp
C30H33N7O8 (619.2390498000001)
Asp Trp His Tyr
C30H33N7O8 (619.2390498000001)
Asp Trp Asn Trp
C30H33N7O8 (619.2390498000001)
Asp Trp Trp Asn
C30H33N7O8 (619.2390498000001)
Asp Trp Tyr His
C30H33N7O8 (619.2390498000001)
Asp Tyr His Trp
C30H33N7O8 (619.2390498000001)
Asp Tyr Trp His
C30H33N7O8 (619.2390498000001)
Phe His Met Trp
Phe His Trp Met
Phe Met His Trp
Phe Met Trp His
Phe Gln Tyr Tyr
Phe Trp His Met
Phe Trp Met His
Phe Tyr Gln Tyr
Phe Tyr Tyr Gln
His Asp Trp Tyr
C30H33N7O8 (619.2390498000001)
His Asp Tyr Trp
C30H33N7O8 (619.2390498000001)
His Phe Met Trp
His Phe Trp Met
His Met Phe Trp
His Met Trp Phe
His Trp Asp Tyr
C30H33N7O8 (619.2390498000001)
His Trp Phe Met
His Trp Met Phe
His Trp Tyr Asp
C30H33N7O8 (619.2390498000001)
His Tyr Asp Trp
C30H33N7O8 (619.2390498000001)
His Tyr Trp Asp
C30H33N7O8 (619.2390498000001)
Met Phe His Trp
Met Phe Trp His
Met His Phe Trp
Met His Trp Phe
Met Trp Phe His
Met Trp His Phe
Asn Asp Trp Trp
C30H33N7O8 (619.2390498000001)
Asn Trp Asp Trp
C30H33N7O8 (619.2390498000001)
Asn Trp Trp Asp
C30H33N7O8 (619.2390498000001)
Gln Phe Tyr Tyr
Gln Thr Trp Trp
Gln Trp Thr Trp
Gln Trp Trp Thr
Gln Tyr Phe Tyr
Gln Tyr Tyr Phe
Thr Gln Trp Trp
Thr Trp Gln Trp
Thr Trp Trp Gln
Trp Asp His Tyr
C30H33N7O8 (619.2390498000001)
Trp Asp Asn Trp
C30H33N7O8 (619.2390498000001)
Trp Asp Trp Asn
C30H33N7O8 (619.2390498000001)
Trp Asp Tyr His
C30H33N7O8 (619.2390498000001)
Trp Phe His Met
Trp Phe Met His
Trp His Asp Tyr
C30H33N7O8 (619.2390498000001)
Trp His Phe Met
Trp His Met Phe
Trp His Tyr Asp
C30H33N7O8 (619.2390498000001)
Trp Met Phe His
Trp Met His Phe
Trp Asn Asp Trp
C30H33N7O8 (619.2390498000001)
Trp Asn Trp Asp
C30H33N7O8 (619.2390498000001)
Trp Gln Thr Trp
Trp Gln Trp Thr
Trp Thr Gln Trp
Trp Thr Trp Gln
Trp Trp Asp Asn
C30H33N7O8 (619.2390498000001)
Trp Trp Asn Asp
C30H33N7O8 (619.2390498000001)
Trp Trp Gln Thr
Trp Trp Thr Gln
Trp Tyr Asp His
C30H33N7O8 (619.2390498000001)
Trp Tyr His Asp
C30H33N7O8 (619.2390498000001)
Tyr Asp His Trp
C30H33N7O8 (619.2390498000001)
Tyr Asp Trp His
C30H33N7O8 (619.2390498000001)
Tyr Phe Gln Tyr
Tyr Phe Tyr Gln
Tyr His Asp Trp
C30H33N7O8 (619.2390498000001)
Tyr His Trp Asp
C30H33N7O8 (619.2390498000001)
Tyr Gln Phe Tyr
Tyr Gln Tyr Phe
Tyr Trp Asp His
C30H33N7O8 (619.2390498000001)
Tyr Trp His Asp
C30H33N7O8 (619.2390498000001)
Tyr Tyr Phe Gln
Tyr Tyr Gln Phe
5-Carboxyrhodamine 6G, succinimidyl ester (5-CR 6G, SE)
(4-{2-Acetylamino-2-[1-(3-carbamoyl-4-cyclohexylmethoxy-phenyl)-ethylcarbamoyl}-ethyl}-2-phosphono-phenoxy)-acetic acid
N-[3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-[[(E)-4-oxo-4-[4-(trifluoromethyl)phenyl]but-2-en-2-yl]amino]propyl]propanamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-methylbenzenesulfonamide
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{2,6-dihydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl}-1-hydroxy-3-methylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-1-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-2-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-{2,6-dihydroxy-4-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl}-2-hydroxy-3-methylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C29H37N3O10S (619.2199542000001)
Vemtoberant
C29H37N3O8S2 (619.2021962000001)
Vemtoberant is an β3 Adrenergic Receptor antagonist. Vemtoberant can be used for research of β3 adrenergic receptor-mediated disorder, such as, heart failure[1][2].
15-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carbaldehyde
C30H37NO13 (619.2264792000001)